Avestar Capital’s Immunomedics Inc IMMU Stock Holding History

Avestar Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-652	Closed	-$9K	–	948
2019 Q2	$9K	Hold	652	–	–	0.01%	522
2019 Q1	$12K	Buy	+652	New	+$10.5K	0.01%	461

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Avestar Capital's IMMU Position: Q3 2019 in Review

Avestar Capital sold out of Immunomedics Inc (IMMU) in Q3 2019, closing a stake of 652 shares — an estimated $9K sold.

Avestar Capital first reported a position in IMMU in Q1 2019 and held it in 2 quarters. The position peaked at $12K in Q1 2019. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

Avestar Capital reported no remaining Immunomedics Inc position as of Q3 2019 after selling out during the quarter.
Avestar Capital sold 652 Immunomedics Inc shares in Q3 2019, an estimated $9K.
Avestar Capital first reported a position in Immunomedics Inc in Q1 2019 and held it in 2 quarters.
Avestar Capital's Immunomedics Inc position peaked at $12K in Q1 2019.
208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.